本頁面由Tiger Trade Technology Pte. Ltd.提供服務

NEWAMSTERDAM PHARMA CO NV

21.16
-1.2000-5.37%
盤前22.080.9200+4.35%08:08 EDT
成交量:173.29萬
成交額:3,698.90萬
市值:25.29億
市盈率:-9.87
高:22.62
開:22.32
低:21.08
收:22.36
52周最高:42.21
52周最低:21.08
股本:1.20億
流通股本:9,251.29萬
量比:0.75
換手率:1.87%
股息:- -
股息率:- -
每股收益(TTM):-2.1442
每股收益(LYR):-1.7211
淨資產收益率:-36.81%
總資產收益率:-20.11%
市淨率:4.01
市盈率(LYR):-12.29

資料載入中...

2025/04/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/07

SEC問詢函

Form CORRESP - Correspondence
2025/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/26

重要事件披露

Form 8-K - Current report
2025/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/10

重要事件披露

Form 8-K - Current report
2025/01/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/12/17

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/17

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/17

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/13

重要事件披露

Form 8-K - Current report
2024/12/10

重要事件披露

Form 8-K - Current report
2024/12/10

重要事件披露

Form 8-K - Current report
2024/11/20

重要事件披露

Form 8-K - Current report
2024/11/18

重要事件披露

Form 8-K - Current report